Group items tagged new - Green Technology

Smart sensors detect wound healing through tissue changes - 1 views

www.medicaldevice-network.com/...smart-wound-sensors

#Smart_Sensors #Researchers #Smart_Wound_Sensors #Developing_Smart_Sensors #Underneath #Bandage

shared by jacob logan on 14 Aug 19 - No Cached

jacob logan on 14 Aug 19

Researchers at Heriot-Watt University in Edinburgh, Scotland are developing smart sensors which can monitor the healing progress of a wound, eliminating the need to look underneath a bandage.

<div class="cArrow"> </div><div class="cContentInner">Researchers at Heriot-Watt University in Edinburgh, Scotland are developing smart sensors which can monitor the healing progress of a wound, eliminating the need to look underneath a bandage.</div>

...

Cancel

Paper heart valves help scientists study calcifying diseases - 1 views

www.medicaldevice-network.com/...paper-heart-valves

#Paper_Heart_Valves #Scientists_Study #Calcifying_Diseases #Rice_University #Bio_Engineers #Heart_Diseases #Medical_Devices

shared by jacob logan on 07 Aug 19 - No Cached

jacob logan on 07 Aug 19

An experimental device made from layered filter paper is helping Rice University bioengineers study calcifying heart diseases. The filter paper is structured in a way that mimics the layering of aortic heart valves, recreating the means by which cells spread through cardiac tissue in a laboratory setting. It may not look much like a heart valve, but in practice it simulates the proliferation process in the same way.

<div class="cArrow"> </div><div class="cContentInner">An experimental device made from layered filter paper is helping Rice University bioengineers study calcifying heart diseases. The filter paper is structured in a way that mimics the layering of aortic heart valves, recreating the means by which cells spread through cardiac tissue in a laboratory setting. It may not look much like a heart valve, but in practice it simulates the proliferation process in the same way.</div>

...

Cancel

BHP to invest $283m in Ruby project development - 1 views

www.offshore-technology.com/...3m-in-ruby-project-development

##Australian_Firm_BHP #BHP #Project_Development #Important_Milestone #volume_Growth

shared by jacob logan on 13 Aug 19 - No Cached

jacob logan on 13 Aug 19

BHP Petroleum Operations president Geraldine Slattery said: "This is an important milestone for BHP in Trinidad and Tobago. Ruby aligns well with our strategy of maximising value from our existing assets, bringing competitive near-term value and volume growth."

<div class="cArrow"> </div><div class="cContentInner">BHP Petroleum Operations president Geraldine Slattery said: "This is an important milestone for BHP in Trinidad and Tobago. Ruby aligns well with our strategy of maximising value from our existing assets, bringing competitive near-term value and volume growth."</div>

...

Cancel

Scottish high street footfall declines 2.8% in July: SRC report - 1 views

www.retail-insight-network.com/...et-footfall-declines-july-2019

#Scottish #Street_Footfall #High_Street_Footfall #Scottish_Retail_Consortium #SRC #Latest_Monthly_Report

shared by jacob logan on 13 Aug 19 - No Cached

jacob logan on 13 Aug 19

Scottish high street footfall fell 2.8% year-on-year in July 2019 across all stores, according to the latest monthly report from the Scottish Retail Consortium (SRC).

<div class="cArrow"> </div><div class="cContentInner">Scottish high street footfall fell 2.8% year-on-year in July 2019 across all stores, according to the latest monthly report from the Scottish Retail Consortium (SRC).</div>

...

Cancel

Siemens Healthineers to acquire Corindus Vascular Robotics for $1.1bn - 1 views

www.medicaldevice-network.com/...ers-corindus-vascular-robotics

#Siemens_Healthcare #Corindus_Vascular_Robotics #Robotics #US_Based #Corindus_Develops #Robotics_System #Medical_Interventions #Treatment

shared by jacob logan on 12 Aug 19 - No Cached

jacob logan on 12 Aug 19

Siemens Healthineers has signed a definitive agreement to acquire all fully diluted shares of US-based Corindus Vascular Robotics. The deal is valued at $4.28 per share in cash or $1.1bn in total. Corindus develops, produces and sells robotic systems for minimally invasive procedures, while Siemens' products use quality imaging before and during medical interventions to make minimally invasive treatment possible.

<div class="cArrow"> </div><div class="cContentInner">Siemens Healthineers has signed a definitive agreement to acquire all fully diluted shares of US-based Corindus Vascular Robotics. The deal is valued at $4.28 per share in cash or $1.1bn in total. Corindus develops, produces and sells robotic systems for minimally invasive procedures, while Siemens' products use quality imaging before and during medical interventions to make minimally invasive treatment possible.</div>

...

Cancel

Global crude prices jump over escalating tensions in the Middle-East - 1 views

www.offshore-technology.com/...ng-tensions-in-the-middle-east

#Global_Crude_prices #Middle_East #Crude_Prices #Saudi_Arabian #Prices_Jump

shared by jacob logan on 20 Aug 19 - No Cached

jacob logan on 20 Aug 19

Crude prices jumped more than 1% after Yemeni separatists carried out a drone attack on a Saudi Arabian oil facility during the weekend. Brent crude climbed 78 cents to $59.42 a barrel, while US crude gained 64 cents to trade at $55.51 per barrel, reported Reuters.

<div class="cArrow"> </div><div class="cContentInner">Crude prices jumped more than 1% after Yemeni separatists carried out a drone attack on a Saudi Arabian oil facility during the weekend. Brent crude climbed 78 cents to $59.42 a barrel, while US crude gained 64 cents to trade at $55.51 per barrel, reported Reuters.</div>

...

Cancel

ESMO 2019: Samsung Bioepis reveals Bevacizumab biosimilar trial result - 1 views

www.clinicaltrialsarena.com/...samsung-bevacizumab-biosimilar

#esmo_2019 #Samsung_Bioepis_reveals # esmo_2019_dates #Bevacizumab #biosimilar_trial_result #non_small_cell_lung_cancer.

shared by jacob logan on 03 Oct 19 - No Cached

jacob logan on 03 Oct 19

A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).

<div class="cArrow"> </div><div class="cContentInner">A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).</div>

...

Cancel

ESMO 2019: Merck unveils neoadjuvant/adjuvant TNBC trial results - 1 views

www.clinicaltrialsarena.com/...nt-adjuvant-tnbc-trial-results

#esmo_2019 #Samsung_Bioepis_reveals #esmo_2019_dates #Bevacizumab #biosimilar_trial_result #non_small_cell_lung_cancer.

shared by jacob logan on 04 Oct 19 - No Cached

jacob logan on 04 Oct 19

A regimen of neoadjuvant Keytruda and chemotherapy extended pathological complete response (pCR) rates by 13.6% compared to chemotherapy alone in patients with early triple-negative breast cancer (TNBC), according to findings from the Phase III Keynote-522 study presented at the ESMO Congress 2019.

<div class="cArrow"> </div><div class="cContentInner"> A regimen of neoadjuvant Keytruda and chemotherapy extended pathological complete response (pCR) rates by 13.6% compared to chemotherapy alone in patients with early triple-negative breast cancer (TNBC), according to findings from the Phase III Keynote-522 study presented at the ESMO Congress 2019.</div>

...

Cancel

BRC reports 1.3% reduction in UK retail footfall in August - 1 views

www.retail-insight-network.com/...il-footfall-uk-down-august-brc

#BRC#UK_Retail_Footfall #August #British_Retail_Consortium

shared by jacob logan on 11 Sep 19 - No Cached

jacob logan on 11 Sep 19

Retail footfall in the UK dropped by 1.3% in August, compared with the 1.6% decline during the same period last year, according to British Retail Consortium (BRC).

<div class="cArrow"> </div><div class="cContentInner">Retail footfall in the UK dropped by 1.3% in August, compared with the 1.6% decline during the same period last year, according to British Retail Consortium (BRC).</div>

...

Cancel

Abbott and Sanofi partner to develop diabetes management tech - 1 views

www.medicaldevice-network.com/...tt-sanofi-diabetes-partnership

#Abbott_And_Sanofi #Abbott_And_Sanofi_Partner #Diabetes_Management_Tech #Delivery_Technology #Ambitions #Diabetes_Manager

shared by jacob logan on 17 Sep 19 - No Cached

jacob logan on 17 Sep 19

Abbott and Sanofi are partnering to integrate their glucose sensing and insulin delivery technologies, with ambitions to simplify how people with diabetes manage their condition.

<div class="cArrow"> </div><div class="cContentInner">Abbott and Sanofi are partnering to integrate their glucose sensing and insulin delivery technologies, with ambitions to simplify how people with diabetes manage their condition.</div>

...

Cancel

Sports Direct announces possible cash offer for Goals Soccer Centres - 1 views

www.retail-insight-network.com/...ts-direct-goals-soccer-centres

#Sport_Direct_Announces #Goals_Soccer_Centres #UK_Retailer #Cash_Offers #Football_Pitch #Direct_Goals

shared by jacob logan on 24 Sep 19 - No Cached

jacob logan on 24 Sep 19

UK retailer Sports Direct has today announced it made a possible cash offer on 5 September 2019 for football pitch operator Goals Soccer Centres at 5p per share.

<div class="cArrow"> </div><div class="cContentInner">UK retailer Sports Direct has today announced it made a possible cash offer on 5 September 2019 for football pitch operator Goals Soccer Centres at 5p per share.</div>

...

Cancel

Woodside to invest in Blue Ocean Seismic Services - 1 views

www.offshore-technology.com/...side-invest-blue-ocean-seismic

#Woodside #Blue_Ocean #Blue_Ocean_Seismic_Services ##Oil_And_Gas_Company #Blue_Ocean_Monitoring

shared by jacob logan on 16 Sep 19 - No Cached

jacob logan on 16 Sep 19

Independent oil and gas company Woodside has signed an agreement with Perth-based Blue Ocean Monitoring (BOM) to invest in technology innovation firm Blue Ocean Seismic Services (BOSS).

<div class="cArrow"> </div><div class="cContentInner"> Independent oil and gas company Woodside has signed an agreement with Perth-based Blue Ocean Monitoring (BOM) to invest in technology innovation firm Blue Ocean Seismic Services (BOSS).</div>

...

Cancel

Top 5 Cool Gadgets To Buy on Amazon Under $15 - YouTube - 0 views

www.youtube.com/watch

To Buy cool gadgets on Amazon New gifts tech awesome

shared by tech92 on 19 Mar 17 - No Cached

tech92 on 19 Mar 17

Top 5 Cool Gadgets To Buy on Amazon Under $15 - YouTube

<div class="cArrow"> </div><div class="cContentInner">Top 5 Cool Gadgets To Buy on Amazon Under $15 - YouTube</div>

...

Cancel

Inside Egypt's record-breaking energy megaproject - 1 views

www.power-technology.com/...ing-energy-megaproject-5806392

energy green

shared by Alex Parker on 18 May 17 - No Cached

Alex Parker on 18 May 17

Siemens has set a new global record for the execution of fast-track power projects by connecting 4.8GW of generation capacity to the Egyptian grid. Julian Turner asks Peter Ullrich, project director of the three combined- cycle power plants at Siemens Power & Gas Division, how it was achieved.

<div class="cArrow"> </div><div class="cContentInner">Siemens has set a new global record for the execution of fast-track power projects by connecting 4.8GW of generation capacity to the Egyptian grid. Julian Turner asks Peter Ullrich, project director of the three combined- cycle power plants at Siemens Power & Gas Division, how it was achieved.</div>

...

Cancel

ESMO 2019: Kisqali shows superior overall survival in breast cancer - 1 views

www.clinicaltrialsarena.com/...esmo-novartis-kisqali

#ESMO_2019 #esmo_conference_2019 #esmo_congress_2019 #Breast_Cancer #esmo_2019_dates

shared by jacob logan on 07 Oct 19 - No Cached

jacob logan on 07 Oct 19

Novartis has said that Kisqali delivered superior overall survival (OS) in the Monaleesa-3 trial, demonstrating more life for postmenopausal human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer patients.

<div class="cArrow"> </div><div class="cContentInner">Novartis has said that Kisqali delivered superior overall survival (OS) in the Monaleesa-3 trial, demonstrating more life for postmenopausal human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer patients.</div>

...

Cancel

ESMO 2019: Ovarian cancer drug fails to meet primary endpoint in study - 1 views

www.clinicaltrialsarena.com/...esmo-immunogen

#ESMO_2019 #ESMO_Conference_2019 #ESMO_Congress_2019 #Digital_Health #ESMO_2019_Meeting

shared by jacob logan on 10 Oct 19 - No Cached

jacob logan on 10 Oct 19

ImmunoGen has presented full data from the Phase III Forward I study of mirvetuximab soravtansine in ovarian cancer at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, saying that it failed to meet the primary endpoint of progression-free survival (PFS).

<div class="cArrow"> </div><div class="cContentInner">ImmunoGen has presented full data from the Phase III Forward I study of mirvetuximab soravtansine in ovarian cancer at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, saying that it failed to meet the primary endpoint of progression-free survival (PFS).</div>

...

Cancel

Blood test may replace biopsy in advanced lung cancer - 1 views

www.medicaldevice-network.com/...lung-cancer-blood-test

#Blood_Test #Replace_Biopsy #Lung_Cancer #NSCLC #Non_Small_Cell_Lung_Cancer #Small_Lung_Cancer #Tumor #Tumor_Treatment

shared by jacob logan on 22 Oct 19 - No Cached

jacob logan on 22 Oct 19

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

<div class="cArrow"> </div><div class="cContentInner">Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.</div>

...

Cancel

UK researchers develop AI-based blood test for brain cancer - 1 views

www.medicaldevice-network.com/...brain-cancer-blood-test

#UK_Researcher #UK_Researcher_Develop #Artificial_Intelligence #AI #Brain_Cancer #Blood_Test

shared by jacob logan on 11 Oct 19 - No Cached

jacob logan on 11 Oct 19

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

<div class="cArrow"> </div><div class="cContentInner"> A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.</div>

...

Cancel

ESMO 2019: Early colon cancer detection blood test has positive result - 0 views

www.medicaldevice-network.com/...so-2019-novigenix-colon-cancer

#ESMO_2019 #Blood_Test #Replace_Biopsy #Lung_Cancer #NSCLC #Non_Small_Cell_Lung_Cancer #Small_Lung_Cancer #Tumor #Tumor_Treatment

shared by jacob logan on 29 Oct 19 - No Cached

jacob logan on 29 Oct 19

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

<div class="cArrow"> </div><div class="cContentInner"> Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.</div>

...

Cancel

MedRhythms launches post-stroke walking rehabilitation device trial - 1 views

www.medicaldevice-network.com/...ng-rehabilitation-device-trial

#MedRhythms #digital_therapeutics #randomised_controlled_trial #rehabilitation_device_trial #Device_trail

shared by jacob logan on 30 Oct 19 - No Cached

jacob logan on 30 Oct 19

MedRhythms, a US-based digital therapeutics company, has launched its five-site randomised controlled trial (RCT) at rehabilitation hospitals and research centres to examine a post-stroke walking rehabilitation device.

<div class="cArrow"> </div><div class="cContentInner">MedRhythms, a US-based digital therapeutics company, has launched its five-site randomised controlled trial (RCT) at rehabilitation hospitals and research centres to examine a post-stroke walking rehabilitation device.</div>

...

Cancel

Group items tagged